S 2295
112th Congress
Senate
Health
Drug safety, medical device, and laboratory regulation
Prescription drugs
Patient Safety and Generic Labeling Improvement Act
Introduced: April 18, 2012
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 18, 2012
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S2498)
Apr 18, 2012
Sponsor introductory remarks on measure. (CR S2497-2498, S2499-2500)
Apr 18, 2012
Introduced in Senate
Plain-English summary
Patient Safety and Generic Labeling Improvement Act - Amends the Federal Food, Drug, and Cosmetic Act to allow the holder of an approved abbreviated new drug application (generic drug approval) to change the labeling of a drug so approved in the same manner authorized by regulation for the holder of an approved new drug application.
Allows conforming changes to be ordered to the labeling of the equivalent listed drug and each drug approved under the abbreviated new drug application process that corresponds to such listed drug.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S2498)
Committees of jurisdiction
1